DLB
Dolby Laboratories, Inc.
DLB's outlook is improving, though it still trails on the overall score.
MU
Micron Technology, Inc.
MU has the edge over DLB overall, supported by stronger fundamentals and stronger modeled upside.
DLB Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Healthy | |
| Strong |
DLB's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
MU Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
MU's revenue, profitability, cash flow and balance sheet are all currently strong.
DLB PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 14x | $64.59 | — |
| Cheap | 27x | $62.50 | -3.2% |
| Current | 28x | $64.59 | — |
| Fair | 32x | $74.76 | +16% |
| Expensive | 40x | $94.26 | +46% |
Historical ranges are pointers, not guarantees.
DLB has the edge over MU in the historical PE scenario, which offers more potential upside but is not a forecast.
MU PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 4.6x | $798 | — |
| Cheap | 10x | $777 | -2.7% |
| Current | 11x | $798 | — |
| Fair | 22x | $1,646 | +106% |
| Expensive | 32x | $2,404 | +201% |
Historical ranges are pointers, not guarantees.
MU's PE is in its cheap range at 11x. If earnings grow as analysts expect, today's price would be 4.6x next year's earnings.
DLB Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Stable | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect DLB's earnings to grow and its profitability to improve, with its revenue holding steady.
MU Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Broad | |
| Moderate |
MU has the edge over DLB on the outlook, with more favorable revenue expectations.
DLB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.58 | +96% |
| Q2 2026 | $2.34 | -14% |
| Q1 2026 | $2.52 | -4.2% |
| Q4 2025 | $2.47 | -8.5% |
| Q3 2025 | $2.62 | -2.6% |
| Q2 2025 | $2.71 | +24% |
| Q1 2025 | $2.63 | +35% |
| Q4 2024 | $2.70 | +41% |
| Q3 2024 | $2.69 | +31% |
DLB earned $2.34 per share over the past year, down 14% from the year before.
MU Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $174.95 | +135% |
| Q3 2026 | $74.33 | +879% |
| Q2 2026 | $44.17 | +693% |
| Q1 2026 | $21.18 | +405% |
| Q4 2025 | $10.52 | +201% |
| Q3 2025 | $7.59 | +984% |
| Q2 2025 | $5.57 | +$6.99 |
| Q1 2025 | $4.19 | +$7.64 |
| Q4 2024 | $3.49 | +$9.77 |
MU has the edge over DLB on earnings, with more consistent year-over-year improvement.
DLB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $305M | -3.3% |
| Q1 2026 | $395.6M | +7.1% |
| Q4 2025 | $346.7M | -2.9% |
| Q3 2025 | $307M | +0.7% |
| Q2 2025 | $315.5M | +9.3% |
| Q1 2025 | $369.6M | +1.4% |
| Q4 2024 | $357M | +13% |
| Q3 2024 | $304.8M | +4.9% |
DLB's revenue grew through 2023 and has held roughly level since: $305M last quarter, down 3.3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 11% | -3.8 points |
| Q1 2026 | 29% | -0.6 points |
| Q4 2025 | 18% | -4.4 points |
| Q3 2025 | 9.7% | -5.5 points |
| Q2 2025 | 15% | +2.4 points |
| Q1 2025 | 29% | -0.7 points |
| Q4 2024 | 22% | +1.4 points |
| Q3 2024 | 15% | +16 points |
DLB's operating margin was 11% last quarter, down 3.8 points from the same quarter a year ago.
MU Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $54.2B | +379% |
| Q2 2026 | $41.5B | +346% |
| Q1 2026 | $23.9B | +196% |
| Q4 2025 | $13.6B | +57% |
| Q3 2025 | $11.3B | +46% |
| Q2 2025 | $9.3B | +37% |
| Q1 2025 | $8.1B | +38% |
| Q4 2024 | $8.7B | +84% |
MU has the edge over DLB on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 81% | +48 points |
| Q2 2026 | 80% | +57 points |
| Q1 2026 | 68% | +46 points |
| Q4 2025 | 45% | +20 points |
| Q3 2025 | 32% | +13 points |
| Q2 2025 | 23% | +13 points |
| Q1 2025 | 22% | +19 points |
| Q4 2024 | 25% | +49 points |
MU has the edge over DLB on profitability, with a higher operating margin.
DLB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $152.5M | +149% |
| Q1 2026 | $83.4M | -50% |
| Q4 2025 | $50.2M | -50% |
| Q3 2025 | $106.6M | -2% |
| Q2 2025 | $61.3M | +349% |
| Q1 2025 | $168M | -2.6% |
| Q4 2024 | $100M | +4229% |
| Q3 2024 | $108.8M | +42% |
DLB's free cash flow has been positive every quarter for seven years: $393M over the past year, down 10% from the year before.
MU Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $32.9B | +45543% |
| Q2 2026 | $17.6B | +951% |
| Q1 2026 | $5.5B | +$5.6B |
| Q4 2025 | $3B | +7853% |
| Q3 2025 | $72M | -75% |
| Q2 2025 | $1.7B | +322% |
| Q1 2025 | -$113M | +$52M |
| Q4 2024 | $38M | +$433M |
MU has the edge over DLB on cash flow, with more consistent year-over-year improvement.
DLB Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -997K shares |
| 1 year | -2.5% | -2.4M shares |
| 3 years | -3% | -2.9M shares |
| 5 years | -9.7% | -10.1M shares |
| Available history | -8.2% | -8.4M shares |
DLB has the edge over MU on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | $65M |
| Q1 2026 | $65M |
| Q4 2025 | $70M |
| Q3 2025 | $35M |
| Q2 2025 | $40M |
| Q1 2025 | $35M |
| Q4 2024 | $15M |
| Q3 2024 | $20M |
DLB spent $235M buying back its own shares over the past year, up 114% from the year before.
MU Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -2M shares |
| 1 year | +1.6% | +18M shares |
| 3 years | +4.6% | +50M shares |
| 5 years | +0.2% | +2M shares |
| Available history | +1.2% | +14M shares |
MU has 1.1B diluted shares, up 1.6% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | $350M |
| Q4 2025 | $300M |
| Q3 2024 | $300M |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
MU has spent almost nothing on buybacks in the past year.
DLB Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | -2.0x | Net Cash |
| Q1 2026 | -1.7x | Net Cash |
| Q4 2025 | -1.9x | Net Cash |
| Q3 2025 | -2.0x | Net Cash |
| Q2 2025 | -1.9x | Net Cash |
| Q1 2025 | -1.8x | Net Cash |
| Q4 2024 | -1.5x | Net Cash |
| Q3 2024 | -1.4x | Net Cash |
DLB has the edge over MU on leverage, with a lower net debt burden relative to earnings.
MU Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.3x | Net Cash |
| Q2 2026 | -0.3x | Net Cash |
| Q1 2026 | -0.1x | Net Cash |
| Q4 2025 | 0.1x | Very low |
| Q3 2025 | 0.3x | Very low |
| Q2 2025 | 0.3x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.6x | Very low |
MU has more cash than debt.
DLB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 58.5 | Neutral |
| Stochastic | 78.1 | Neutral |
DLB's weekly RSI is 58 (neutral) and its Stochastic is 78 (neutral).
MU Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 47.1 | Neutral |
| Stochastic | 26.9 | Neutral |
MU's weekly RSI is 47 (neutral) and its Stochastic is 27 (neutral).
DLB PE vs Technology Sector
| Metric | DLB | Sector median | Relative |
|---|---|---|---|
| PE | 28x | 28x | 0.9% below |
| PE % | 22 | 35 | 13 pts below |
DLB is trading at 28x earnings, in line with the Technology sector's median of 28x.
MU PE vs Technology Sector
| Metric | MU | Sector median | Relative |
|---|---|---|---|
| PE | 11x | 28x | 61% below |
| PE % | 18 | 35 | 17 pts below |
MU has the edge over DLB on valuation relative to its sector.
DLB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $61.3 | 5.4% above |
| 20 week MA | $59.2 | 9.1% above |
| 50 week MA | $60.3 | 7.1% above |
| 100 week MA | $67.5 | 4.4% below |
| 200 week MA | $74.3 | 13% below |
DLB has bounced recently, but its long-term trend is still down: it's above its 8-, 20- and 50-week averages, but 13% below its 200-week average.
MU Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $914.5 | 13% below |
| 20 week MA | $931.0 | 14% below |
| 50 week MA | $685.9 | 16% above |
| 100 week MA | $405.4 | 97% above |
| 200 week MA | $246.0 | 225% above |
MU has pulled back, but its long-term trend is still up: it's below its 8- and 20-week averages, but 225% above its 200-week average.
DLB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $68.3 | $95.3 | +39% |
| 2021 | $95.3 | $92.7 | -2.7% |
| 2022 | $92.7 | $69.2 | -25% |
| 2023 | $69.2 | $86.2 | +24% |
| 2024 | $86.2 | $78.5 | -8.9% |
| 2025 | $78.5 | $65.7 | -16% |
| 2026 YTD | $65.7 | $64.6 | -1.7% |
DLB has finished lower in four of the last six years. It's down 1.7% so far in 2026.
MU Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $54.0 | $70.6 | +31% |
| 2021 | $70.6 | $94.4 | +34% |
| 2022 | $94.4 | $50.2 | -47% |
| 2023 | $50.2 | $85.3 | +70% |
| 2024 | $85.3 | $88.6 | +3.9% |
| 2025 | $88.6 | $284.8 | +221% |
| 2026 YTD | $284.8 | $798.4 | +180% |
MU has the edge over DLB on returns for 2026, with the stronger performance.